News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2024
August 2024
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
ASCO 24 cant’s-miss events
Photo taken from ASCO/X
May 17, 2024, 02:57

ASCO 24 cant’s-miss events

ASCO made the following post on X:

“Are you ready for ASCO24? Preview this year’s can’t-miss events, new opportunities to connect with colleagues, and additional features for 2024 to personalize your meeting experience and make the most of every session you attend.”

Read further.
Source: ASCO/X

ASCO ASCO24 cancer Colleague connections Conference updates Continuing education Medical Networking Meeting features OncoDaily Oncology Oncology Conference Personalized experience professional development Session highlights
Positive
Aug 14, 2024, 10:05
There's no sound sweeter than the ringing of the survivor bell - City of Hope Orange County
Career
Aug 14, 2024, 09:59
Free learning opportunity for radiation oncology residents - Radiation Oncology Institute
Societies
Aug 14, 2024, 09:40
Join Lung Policy to find out how to promote change in your area - IASLC
Blog
Aug 14, 2024, 09:02
GIAHC - Shoba Krishnan shares insights on cost-effective cancer therapy
Blog
Aug 14, 2024, 08:44
Improving cancer care in conflict-impacted populations by Julie Gralow et al - ASCO
Insight
Aug 14, 2024, 07:49
New LBCL CNS prophylaxis guidelines by Matt Wilson et al.
Societies
Aug 14, 2024, 07:37
Sylvester Comprehensive Cancer Center's 20-week “Believe in You” fitness training program
Insight
Aug 14, 2024, 07:35
Elisa Agostinetto: The sub-analysis of the EMERALD trial
Insight
Aug 14, 2024, 07:33
Olanzapine as antiemetic prophylaxis in chemotherapy
Societies
Aug 14, 2024, 07:30
Developing a mobile app to address the daily challenges of cancer patients and survivors by EU smartCARE
Career
Aug 14, 2024, 07:24
Christine Ryland as Director of Thought Leader Liaison for the multiple myeloma team at Kite Pharma
Drugs
Aug 14, 2024, 07:20
Keith W Pratz: Novel risk signature for AML treated with Azacitidine and Venetoclax